# The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study

> **NCT02208492** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 75 (actual)

## Conditions studied

- Focal Epilepsy

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Carabamazepine

## Key facts

- **NCT ID:** NCT02208492
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2014-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02208492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02208492, "The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02208492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*